欢迎来到铭开生物!

Suzhou Mingchem Pharmtech Co., Ltd

   
Home > News > Industry News

Analysis on the present situation of pharmaceutical intermediate industry

2016-07-19 14:12:09 Suzhou Mingchem Pharmtech Co., Ltd Read

Analysis on the present situation of pharmaceutical intermediate industry

After the last century in the late 90s brilliant, pharmaceutical intermediates industry has basically entered the mature stage. The competition between enterprises has reached a white hot, each in a fight last strength, who can stick to the end, who is a survivor. At the same time, by the temptation of all kinds of legends and other factors, there are new investors with "gold rush" dream to enter the industry. However, with the national requirements of pharmaceutical enterprises in the rise of GMP certification and certification of overseas, the scale of investment in the pharmaceutical industry is geometrically increasing, how to make limited funds and energy, produce the maximum economic benefit and social benefit, has become the goal pursued by each of the pharmaceutical intermediate investors.

[track] from the medicine, go to the medicine

The impact of economic globalization, influence to our country economy the most profound, nothing is more than its philosophy, namely each production enterprise, there is no need to do big and complete, should the funds and focus on their specialized industries and fields and other supporting materials and conditions can be by a social collaboration. Through the formation of a product chain, so that the two sides to achieve win-win cooperation. Under the influence of this idea, the pharmaceutical industry will be a number of primary products processing, such as solvent recovery and other work referred to the completion of the cooperative enterprise. In the future, there will be some of the certain pollution and dangerous products, referred to the production of chemical plants, such as the use of penicillin production of acetic acid, acetic acid, acetic acid, acetic acid, acetic acid. In the vicinity of Shijiazhuang, since the last century 70, 80s, there have been a large number of pharmaceutical companies in North China for the production of benzene acetic acid and acetic acid small township enterprises and individual enterprises.

With the cooperation between the two sides of the deepening, pharmaceutical enterprises will gradually some high added value, difficulty of technology products, are also transferred to the chemical factory production, such as the production of cephalosporin antibiotics use of cefotaxime acid, AE active ester, triazine ring, tetrazole acetic acid, p-hydroxybenzoic Gan ammonia acid (Deng sylvite), Ho - ERCP etc. products. This makes the branch industry in the last century has been rapid development in 90s, the achievement of a number of output value of tens of millions to billions of pharmaceutical intermediates. Such as Zhejiang Yongning pharmaceutical factory, Fushun meiqiang pharmaceutical factory, Zhejiang Hengdian to bang group, Shandong Ruiying group, Shandong Jincheng Chemical Plant of many enterprises.

At present, the industry has been developed to more closely with the pharmaceutical industry cooperation, the production of pharmaceutical intermediates by manufacturers, which was directly synthesized APIs (bacterial powder), and the product in the form of chemical products sold to pharmaceutical companies, refined and sold as a medicine. Pharmaceutical intermediates industry can extend the product chain, increase profits and improve the stability of sales, and pharmaceutical enterprise reduces the investment and the limited money and effort, put in his own good aseptic packaging. Because pharmaceutical intermediate industry does not have the production license of pharmaceutical products, it is impossible to compete with pharmaceutical companies for market, so the cooperation between the two sides has a certain complementarity.

The most basic condition is still restricting the development of

In recent years, pharmaceutical intermediates industry rapid development, caused many investors covet, across the country to produce pharmaceutical intermediates bulk drug enterprises mushroomed gush, but again at the same time in order to approximate the velocity was eliminated. Many technical personnel engaged in the development of pharmaceutical intermediates, but also in various forms involved in the industry, but with the closure of the corresponding enterprises, but also have to return. The development of this industry seems to ebb and flow, took many losers hurried back. The as one of the many failures, after the calm reflection, I humbly believe, in the industry of many human and financial reason "hurrying", is not the industry has been developed to meet the new bottleneck, and is mainly due to the most basic, but is often forgotten by many "gold" conditions did not have restricted. The following are some of the necessary conditions for the success of pharmaceutical intermediate enterprises.

Sun Tzu said: Ten Wai, five attack, times are, the enemy can battle, less able to escape, not if you can avoid. Shopping malls such as the battlefield, in the current situation, there is no ten million of the funds, in the pharmaceutical intermediate industry, there is no chance of survival. Although money is a key question in shopping malls on the same, but the industry competition in the market has developed to the extent that such a fierce today, don't give new enterprises to calm development opportunities, participants should carefully consider.

The technical requirements of the product in the industry is very strict, and in the continuous development, and therefore require the production of pharmaceutical intermediate enterprises have strong technical force. And, in the product line extension of the trend is increasingly clear today, how to meet the requirements from the upstream companies continue to introduce trial production of new products, is already lie in front of the pharmaceutical intermediates business technical problems, how to effectively solve this problem is the focus of the future development of the enterprise. Only rely on "digging the foundation", stealing technology from other enterprises, steal the talent, only temporary emergency, not a permanent solution. Human right is the vicissitudes of life, and it is a man of tremendous promise Jiminggoudao?

With the funds, with the technology, can produce products. But only the product sold out, and in a timely manner to recover the funds, the party can be reproduced. Because there is a close relationship between the pharmaceutical intermediate industry and the pharmaceutical industry, the sales of the products are very delicate. Competition between suppliers

Powered by JUYISEO 5.3.8 ©2008-2019 www.juyiseo.com